Application of Stellate Ganglion Block in Breast Cancer Surgery: a Randomized Controlled Trial

Application of Ultrasound-Guided Stellate Ganglion Block in Breast Cancer Surgery: a Randomized Controlled Trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032658

Enrollment

Unknown

Registered

2020-05-05

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

control group:TIVA

experimental group:TIVA combined with SGB

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 60 women of American Socity of Anesthesiologists physical status I to III, aged 18 to 70 years, schedule for elective unilateral breast cancer surgery.

Exclusion criteria

Exclusion criteria: Severe hypertension, abnormal heptic or renal function. A history of allergy to local anaesthetics, known coagualtion disorders, infection near the puncture site, chronic analgesic use, inability to communicate.

Design outcomes

Primary

Measure	Time frame
Quality of recovery score;	—

Secondary

Measure	Time frame
The score of skin incision pain at different time after operation;Postoperative gastrointestinal function changes;	—

Countries

China

Contacts

Public ContactLijian Chen

The First Affiliated Hospital of Anhui Medical University

chenlijian77@126.com+86 13966699467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026